The global Hemostats Market is projected to reach USD 4.93 billion by 2032
From GlobeNewswire: 2025-03-13 09:11:00
The global Hemostats Market was valued at USD 2.74 billion in 2023, expected to reach USD 4.93 billion by 2032, with a CAGR of 6.76%. Factors driving growth include increased surgeries, advancements in hemostatic agents, and rising demand for blood control products. Technological advancements and demographic trends further boost market growth.
Key companies in the market are Johnson & Johnson, CryoLife, Inc, Integra LifeSciences Corporation, Pfizer, B. Braun Melsungen AG, BD, Medtronic, Baxter, Stryker Corporation, and Z-Medica. Hemostats Market Report Scope includes market size, CAGR, regional coverage, and segment analysis based on type, formulation, application, and end-use.
Oxidized regenerated cellulose-based hemostats dominated the market in 2023, accounting for 43.9% of revenue. Combination hemostats are expected to be the fastest-growing segment due to their effectiveness in controlling bleeding. Matrix & gel hemostats were the leading formulation, while orthopedic procedures had the highest market share in application.
Hospitals and clinics were the largest end-users of hemostats in 2023, with a market share of 45.02%. Casualty care facilities are projected to have the highest growth rate, driven by increased trauma cases and emergency procedures. North America led the market in 2023, while the Asia-Pacific region is expected to witness the highest growth rate in the future. The Hemostats market in the region is experiencing growth due to increased healthcare spending, an aging population, and rising number of surgeries in countries like India and China. Investments in healthcare infrastructure and awareness about new surgical procedures are driving adoption of hemostats at a rapid pace.
Recent developments in the Hemostats market include Medcura, Inc. winning the Best Technology in Spine Award for its LifeGel Absorbable Hemostatic Gel, Baxter International Inc. introducing PERCLOT Absorbable Hemostatic Powder in the U.S., and Olympus launching new hemostatic treatment solutions in the EMEA market.
The Hemostats market analysis report for 2024-2032 covers key points such as market dynamics impact analysis, statistical insights and trends reporting, competitive landscape, company profiles, regional analysis, and more. SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data and insights to make informed decisions.
Read more at GlobeNewswire: Hemostats Market to Hit USD 4.93 Billion by 2032, Driven by